Tweet
Tech Times |
Esbriet, Ofev Approved to Treat Deadly Lung Disease U.S. News & World Report THURSDAY, Oct. 16, 2014 (HealthDay News) -- Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF). Approval was ... Health Highlights: Oct. 16, 2014Philly.com Boehringer Ingelheim and InterMune IPF Drugs ApprovedMedPage Today FDA Approves Two Drugs as First Treatments For Fatal Lung DiseaseHeadlines & Global News FiercePharma -Daily Digest -Financialbuzz.com all 132 news articles » |
More...